Averting a malaria disaster

As treatments loose their effectiveness, morbidity and mortality from malaria will inevitably continue to rise. The rationale for combining drugs with independent modes of action is examined.

Saved in:

Bibliographic Details
Published in:	The Lancet (British edition) Vol. 353; no. 9168; pp. 1965 - 1967
Main Authors:	White, NJ, Nosten, F, Looareesuwan, S, Watkins, WM, Marsh, K, Snow, RW, Kokwaro, G, Ouma, J, Hien, TT, Molyneux, ME, Taylor, TE, Newbold, CI, Ruebush, TK, Danis, M, Greenwood, BM, Anderson, RM, Olliaro, P
Format:	Journal Article
Language:	English
Published:	London Elsevier Ltd 05.06.1999 Lancet Elsevier Limited
Subjects:	Animals Antimalarials - economics Antimalarials - therapeutic use Artemisinins Biological and medical sciences Costs and Cost Analysis Drug Resistance Drug therapy Drug Therapy, Combination Drugs, Chinese Herbal - therapeutic use Human protozoal diseases Humans Infectious diseases Malaria Malaria, Falciparum - drug therapy Malaria, Falciparum - epidemiology Malaria, Falciparum - prevention & control Medical research Medical sciences Parasitic diseases Protozoal diseases Pyrimethamine - therapeutic use Sesquiterpenes - therapeutic use Sulfadoxine - therapeutic use Tropical medicine Vector-borne diseases Epidemic Human Antimalarial Protozoal disease Chemoprophylaxis Costs Malaria Toxicity Artemisinin Parasitosis Infection Prevention Resistance Treatment Parasiticid
ISSN:	0140-6736, 1474-547X
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!